Transcatheter Aortic Valve Replacement (TAVR) Medical Device Supply

This contract involves the procurement and delivery of a Transcatheter Aortic Valve Replacement (TAVR) medical device, intended for minimally invasive heart valve replacement procedures at Department of Veterans Affairs facilities. The contract is issued by the Network Contract Office 23 under the Department of Veterans Affairs, categorized within the NAICS code 339113, which pertains to medical equipment manufacturing. While specific details such as the solicitation number, place of performance, and points of contact are not provided, the contract is classified as a subcontract and is focused on supplying specialized medical devices that support advanced cardiac care for veterans. The purpose of this contract is to ensure the availability and supply of TAVR devices that facilitate less invasive cardiovascular treatments, improving patient outcomes and recovery times in VA healthcare settings. The contract posted on May 29, 2026, demonstrates the VA's commitment to enhancing its medical capabilities through the acquisition of cutting-edge technology, aligning with its mission to provide high-quality care to veterans. The emphasis on this subcontract highlights the VA’s strategy to partner with specialized suppliers to meet the complex needs of its medical programs.